Global Cervical Cancer Endoscopic Devices Market (2019-2023): Companies are Focusing on Developing Portable Smart & Pocket Colposcopes - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--May 21, 2019--
The “Global Cervical Cancer Endoscopic Devices Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.
The cervical cancer endoscopic devices market will register a CAGR of almost 6% by 2023.
The increasing number of cervical cancer endoscopic device launches is one of the key factors that will trigger the market growth during the forecast period.
With the rising prevalence of cervical cancer, manufacturers are focusing on developing advanced diagnostic products which can improve the efficacy of cervical cancer diagnosis. Moreover, many companies are also focusing on developing portable and fixed cervical cancer endoscopic devices and are launching products in various economies.
Therefore, product approvals by regulatory departments and launch of products will help companies to increase product sales and grow product-related awareness, which will boost the market growth during the forecast period.
Increasing prevalence of cervical cancer
With the rising prevalence of cervical cancer, there has been a growing demand for smart colposcopes. The growing partnerships between manufacturers and end-users will boost the adoption of cervical cancer endoscopic devices.
Shortage of skilled professional
With the increasing number of cervical cancer cases, there is a growing need for skilled professionals. Hence, the shortage of skilled professionals can reduce the adoption of cervical cancer endoscopic devices.
The market appears to be fragmented with the presence of several market players. The high cost of conventional colposcopes can negatively impact market growth, due to which companies are focusing on developing portable smart and pocket colposcopes which are available at low cost.
This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY PRODUCT
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
PART 09: DRIVERS AND CHALLENGES
PART 10: MARKET TRENDS
PART 11: VENDOR LANDSCAPE
PART 12: VENDOR ANALYSIS
For more information about this report visit https://www.researchandmarkets.com/r/q5a1ab
View source version on businesswire.com:https://www.businesswire.com/news/home/20190521005704/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Cervical Cancer Drugs ,Endoscopy
INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 05/21/2019 11:32 AM/DISC: 05/21/2019 11:32 AM